Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._
Year: 2025
Type: article
Language: en
Topic: HIV Research and Treatment
Authors and affiliations:
raw_author_name: Lucia Bailón
raw_affiliation_strings: Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Department of Medicine, Autonomous University of Barcelona, Cerdanyola del Vallés, Spain
raw_author_name: Yovaninna Alarcón-Soto
raw_affiliation_strings: Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
raw_author_name: José R. Arribas
raw_affiliation_strings: CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Department of Internal Medicine, Infectious Disease Unit, Hospital Universitario La Paz, Madrid, Spain
Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
raw_author_name: Adrian Curran
raw_affiliation_strings: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain
raw_author_name: Anuska Llano
raw_affiliation_strings: Unitat Secretaria Tècnica CEIm Parc Taulí. Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Sabadell, Spain
raw_author_name: Samandhy Cedeño
raw_affiliation_strings: IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
raw_author_name: Roger Paredes
raw_affiliation_strings: CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Department of Infectious Diseases and Immunity, University of Vic-Central University of Catalonia, Vic, Spain
Department of Pathology, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, USA
IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Universitat Politècnica de Catalunya - BarcelonaTech, Terrassa, Spain
raw_author_name: Elena Vendrame
raw_affiliation_strings: Gilead Sciences, Inc, Foster City, CA, USA
raw_author_name: Devi SenGupta
raw_affiliation_strings: Gilead Sciences, Inc, Foster City, CA, USA
raw_author_name: Jeffrey J. Wallin
raw_affiliation_strings: Gilead Sciences, Inc, Foster City, CA, USA
raw_author_name: Romas Geleziunas
raw_affiliation_strings: Gilead Sciences, Inc, Foster City, CA, USA
raw_author_name: Marie P. Malice
raw_affiliation_strings: StatAdvice, Inc, Brussels, Belgium
raw_author_name: Ian McGowan
raw_affiliation_strings: AELIX Therapeutics S.L, Barcelona, Spain
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
raw_author_name: Christian Brander
raw_affiliation_strings: AELIX Therapeutics S.L, Barcelona, Spain. cbrander@irsicaixa.es
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. cbrander@irsicaixa.es
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. cbrander@irsicaixa.es
Department of Pathology, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, USA. cbrander@irsicaixa.es
IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. cbrander@irsicaixa.es
Department of Pathology, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, USA
IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
raw_author_name: José Moltó
raw_affiliation_strings: CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. jmolto@lluita.org
Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmolto@lluita.org
Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
raw_author_name: Beatriz Mothe
raw_affiliation_strings: CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
Department of Infectious Diseases and Fundació Lluita contra les Infeccions, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Department of Pathology, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, USA
IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Spain